India to roll out biometric authentication for instant digital payments from Wednesday, sources say


A QR code sticker of the digital payment app Paytm is seen outside a grocery store in Kolkata, India July 9, 2024. REUTERS/Sahiba Chawdhary 

MUMBAI (Reuters) -India will allow users to approve payments made through popular domestic payments network, the Unified Payments Interface, using facial recognition and fingerprints starting October 8, three sources directly familiar with the matter said on Tuesday.

Authentications will be done using biometric data stored under the Government of India's unique identification system - Aadhar, one of the sources said.

The move follows recent guidelines from the Reserve Bank of India permitting alternative methods of authentication and will mark a departure from the current system, which requires a numeric PIN for payment authentication.

The National Payments Corporation of India, which operates UPI, plans to showcase this new biometric feature at the ongoing Global Fintech Festival in Mumbai, the sources said on condition of anonymity as they are not authorised to speak to the media.

NPCI did not immediately respond to a Reuters' request for comment.

(Reporting by Jaspreet Kalra and Ashwin Manikandan; Editing by Sumana Nandy)

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Tech News

Rohm, Toshiba, Mitsubishi Electric to begin power chip integration talks, Nikkei says
South Korea to invest $166 million in AI chip startup Rebellions
In NYC classes, teachers can use AI to plan but not to assign grades
Google top India counsel quits in latest departure amid regulatory hurdles, sources say
Uber, Pony.ai and Verne team up to launch Europe's first robotaxi service in Croatia
The EU’s biggest test for device makers: Replaceable batteries
US activists work to connect Iranians via Starlink
New on the iPhone: Shazam songs even when offline with iOS 26.4
First Robot: Melania Trump brings droid to White House event
Why AI means animal testing is not always needed to trial new medicines

Others Also Read